13F filing recap · Q4 2015
What did ArrowMark Partners buy in Q4 2015?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$3.65B
Positions
263
Estimated turnover
25.5%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
WABWestinghouse Air Brake Technologies Corporation$26.24Mreported value+369.0K sharesBLUEBluebird Bio, Inc.$15.95Mreported value+248.3K sharesCELGCelgene Corporation$12.70Mreported value+106.0K sharesDEODiageo Plc$10.09Mreported value+92.5K sharesFITFitbit Inc$6.79Mreported value+229.5K sharesTTETotalenergies SE$5.39Mreported value+120.0K sharesAGIOAgios Pharmaceuticals, Inc.$3.92Mreported value+60.4K sharesCVLTCommvault Systems Inc$2.36Mreported value+60.0K sharesPACBPacific Biosciences of California, Inc.$2.19Mreported value+167.0K sharesFORRForrester Research, Inc.$1.59Mreported value+55.7K sharesGOOGLAlphabet Inc.$1.53Mreported value+2.0K sharesYHOOAltaba Inc.$765.0Kreported value+23.0K sharesIPIIntrepid Potash, Inc.$418.0Kreported value+141.7K sharesTEAMAtlassian Corporation$301.0Kreported value+10.0K shares